Nasdaq Pcvx News Today

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $61.92, for a total value of $928,800.00. Following the completion of the sale, the chief executive officer now directly owns 477,847 shares of […]

Vaxcyte (NASDAQ:PCVX – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Vaxcyte and Avalon GloboCare’s net […]

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the company’s stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $61.27, for a total value of $490,160.00. Following the completion of the transaction, the chief financial officer now directly owns 95,679 shares […]

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average recommendation of “Buy” from the five ratings firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued ratings on the stock in […]

Vaxcyte (NASDAQ:PCVX – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.89) by ($0.93), Briefing.com reports. During the same quarter in the prior year, the business posted ($0.73) earnings per share. Vaxcyte Price Performance Vaxcyte stock traded […]

Westfield Capital Management Co. LP purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the third quarter, HoldingsChannel reports. The fund purchased 1,003,916 shares of the company’s stock, valued at approximately $51,180,000. Other institutional investors and hedge funds have also modified their holdings of the company. Jennison Associates LLC grew its holdings […]

Rathbones Group PLC acquired a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,330 shares of the company’s stock, valued at approximately $221,000. Other hedge funds and other institutional investors have also […]

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have updated their coverage on the stock in the last […]

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $73.87, for a total transaction of $123,141.29. Following the completion of the transaction, the senior vice president now owns 20,710 shares of […]